loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ingenol Mebutate

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ingenol Mebutate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Risks of Picato for actinic keratosis outweigh benefits
    Risks of Picato for actinic keratosis outweigh benefits

    30 Apr 2020

    // EMA

    https://www.ema.europa.eu/en/news/risks-picato-actinic-keratosis-outweigh-benefits

    EMA
    30 Apr 2020
    Share Share
    EMA confirms skin cancer risk with LEO's Picato
    EMA confirms skin cancer risk with LEO's Picato

    20 Apr 2020

    // Selina McKee PHARMATIMES

    http://www.pharmatimes.com/news/ema_confirms_skin_cancer_risk_with_leos_picato_1338594

    Selina McKee PHARMATIMES
    20 Apr 2020
    Share Share
    EMA Begins Publishing All Health Professional Communications
    EMA Begins Publishing All Health Professional Communications

    14 Feb 2020

    // Michael Mezher RAPS

    https://www.raps.org/news-and-articles/news-articles/2020/2/ema-begins-publishing-all-health-professional-comm

    Michael Mezher RAPS
    14 Feb 2020
    Share Share
    Ingenol mebutate gel: suspension of the licence due to risk of skin malignancy
    Ingenol mebutate gel: suspension of the licence due to risk of skin malignancy

    13 Feb 2020

    // GOVUK

    https://www.gov.uk/drug-safety-update/ingenol-mebutate-gel-picato-suspension-of-the-licence-due-to-risk-of-skin-malignancy

    GOVUK
    13 Feb 2020
    Share Share
    LEO issues Picato recall
    LEO issues Picato recall

    01 Feb 2020

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/leo_issues_picato_recall_1323880

    Anna Smith PHARMA TIMES
    01 Feb 2020
    Share Share
    EMA suspends Picato as a precaution while review of skin cancer risk continue
    EMA suspends Picato as a precaution while review of skin cancer risk continue

    18 Jan 2020

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-january-2020

    EMA
    18 Jan 2020
    Share Share